We are live on ! Find out more
KL

KCK Ltd Portfolio holdings

AUM $15.1M
1-Year Est. Return 30.14%
This Fund
S&P 500
This Quarter Est. Return
-34.02%
1 Year Est. Return
+30.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.5M
AUM Growth
-$64.4M
Cap. Flow
-$59M
Cap. Flow %
-559.62%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NPCE icon
Neuropace
NPCE
+$59M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGHT icon
1
Sight Sciences
SGHT
$286M
$10.5M 99.62%
4,374,975
– –
RNTX
2
Rein Therapeutics
RNTX
$63.1M
$39.5K 0.38%
22,341
– –
NPCE icon
3
Neuropace
NPCE
$439M
– –
-5,270,845
Closed -$59M

Similar funds

LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return
AVM
Avalon Ventures Management La Jolla, California $14.2M AUM 9.35% 1-Year Est. Return
RCMU
Rokos Capital Management (US) New York $14.2M AUM
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
SI
SQN Investors Menlo Park, California $12.8M AUM
TAC
Twenty Acre Capital Newtown, Pennsylvania $12.4M AUM 49.87% 1-Year Est. Return
DADR
Dynamo Administracao de Recursos Rio De Janeiro, Brazil $18.5M AUM 37.41% 1-Year Est. Return
PM
Pharo Management New York $18.7M AUM

KCK Ltd's Q1 2025 Portfolio in Review

As of Q1 2025, KCK Ltd held 3 positions worth $10.5M, down 86% from $75M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KCK Ltd withdrew a net $59M in Q1 2025, closing 1 position. Its most notable exit was Neuropace, an estimated $59M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • KCK Ltd fully exited Neuropace in Q1 2025, selling an estimated $59M.
  • KCK Ltd's ten largest holdings make up 100% of its $10.5M portfolio in Q1 2025.
  • KCK Ltd opened 0 new positions and closed 1 in Q1 2025.
  • KCK Ltd's portfolio value fell 86% quarter-over-quarter to $10.5M.

Based on KCK Ltd's 13F filing for Q1 2025, filed 11 Jul 2025.